Established in 2020 Saturday, January 16, 2021

Success of COVID-19 vaccination program depends on its implementation
An illustration picture taken on November 19, 2020, shows a vial with Covid-19 Vaccine sticker, a syringe and an earth globe. Joel Saget / AFP.

NEW HAVEN, CT.- Factors related to manufacturing, distribution, public acceptance, and the severity of the pandemic will contribute more to the success of a potential COVID-19 vaccination program than the efficacy of the vaccine itself, finds a new study conducted by the Yale School of Public Health.

The research, published Nov. 19 in Health Affairs, comes as the global effort to develop a COVID-19 vaccine is poised to produce one or more candidates approved for large-scale distribution. In the United States, the Food and Drug Administration is grappling to define the evidence it will require to authorize COVID-19 vaccines in the months ahead.

For instance, would a vaccine that has a limited impact on transmission but significantly reduces progression to severe disease be acceptable? Alternatively, how might such a vaccine be compared to one that lowers susceptibility to infection but has no impact on disease progression? Once vaccination begins, what individual and public health benefits should the public expect from vaccines based on their performance in clinical trials? Finally, what other factors will shape the success of COVID-19 vaccination programs?

Investigators led by A. David Paltiel, professor of public health (health policy) at YSPH, began by assembling data on the epidemiology of SARS-CoV-2 and the natural history of COVID-19. They then used an original mathematical model to estimate cumulative infections, hospitalizations, and deaths. Furthermore, they characterized the success of a vaccination program based on a number of interacting factors: the efficacy of the vaccine, the speed of manufacturing and distribution, the persuasiveness of public campaigns to promote vaccine acceptance, and the severity of the pandemic when the vaccine is introduced into the community.

“Infrastructure will contribute at least as much to the success of the vaccination program as will the vaccine itself,” said Paltiel. “The population benefits of vaccination will decline rapidly in the face of manufacturing or deployment delays, significant vaccine hesitancy, or greater epidemic severity.”

The findings highlight the urgent need for health officials to invest greater financial resources and attention to vaccine production and distribution programs and to redouble efforts to promote public confidence in COVID-19 vaccines, said study author Jason L. Schwartz, assistant professor in the Department of Health Policy and Management at YSPH.

“Even with a highly effective vaccine, we will still need sustained adherence to masking, physical distancing, and other mitigation practices for some time to bring the public health crisis under control,” Schwartz said.

The study was co-authored by Amy Zheng of the Harvard Medical School and Rochelle P. Walensky of Massachusetts General Hospital and Harvard Medical School. The research was supported by grants from the National Institutes of Health and the Steve and Deborah Gorlin MGH Research Scholars Award.

Today's News

November 21, 2020

Small molecule, big potential for treating prostate cancer

COVID-19 patients survive in-hospital cardiac arrest at pre-pandemic rates

Decoding the way catalysts work

UK asks regulator to study Pfizer/BioNTech vaccine

Coronavirus treatments: some progress, no panacea

A biochemical random number

CUHK researchers hope to boost immunity for SARS-CoV-2

New Chinese submersible reaches Earth's deepest ocean trench

Potential cellular target for eliminating bone breakdown in osteoporosis found

Success of COVID-19 vaccination program depends on its implementation

Student team develops noninvasive endometriosis test

Researchers peer inside deadly pathogen's burglary kit

Banking on patient samples to advance COVID-19 research

New green materials could power smart devices using ambient light

Found: a genetic link to molecular events that precede symptoms in Alzheimer's disease

Stanford researchers explore potential for kelp to relieve ocean acidification

Applying environmental genomics to coral conservation

Baby panda born in Netherlands makes public debut


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez

Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful